Results 241 to 250 of about 898,450 (282)

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025. [PDF]

CPT Pharmacometrics Syst Pharmacol
Cordes H, Annaert P, Balazki P, Benamara S, Bonan RH, Butler A, Chenel M, Cui Y, Dallmann A, de Witte WEA, Demeester C, Feick D, Gattacceca F, Geci R, Gerebtzoff G, Gruber A, Guimarães M, Hamadeh A, Hanke N, Ibarra M, Ince I, Kanacher T, Kuepfer L, Mil F, Montaseri G, Nauwelaerts N, Proenca S, Schaller S, Schlender JF, Schneider ARP, Sjögren E, Solodenko J, Staab A, Vrenken P, Troisi C, Teutonico D.   +35 more
europepmc   +1 more source

Opinion: Gavage Administration of MXene as a Route‐Specific Alternative to Intravenous Injection into the Bloodstream of Laboratory Animals for Reducing Systemic Nanotoxicity Risks in Immunosuppression and Post‐Transplantation Models with Bile Acid Modification

Advanced Healthcare Materials, EarlyView.
Recent studies reported immunosuppressive properties of specific MXene nanomaterials. Their intravenous injection into the bloodstream of laboratory animals has been a common delivery method to suppress systemic inflammation and prevent transplant rejection.
Alireza Rafieerad, M. Akif Rahman, Ahmad Amiri   +2 more
wiley   +1 more source

Mining personalized core traditional Chinese medicine prescriptions for rheumatoid arthritis and elucidating their mechanisms via frequent closed Itemset compression and multilevel network pharmacology. [PDF]

Front Mol Biosci
Chen X, Yu J, Dong X, Chen Z, Tian J, Zhao M, Jiang M, Guo H, Zhou X, Fa L, Li Y, Zhang L.   +11 more
europepmc   +1 more source

Correction to: Associations of sphingosine‑1‑phosphate with soluble P‑selectin and adverse clinical outcome in patients with cerebral ischemia with and without acetylsalicylic acid treatment. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Gloyer NO, Moritz E, Schwieren L, Meyer U, Thomalla G, Daum G, Magnus T, Böger R, Choe CU, Rauch BH, Schwedhelm E.   +10 more
europepmc   +1 more source

Team-based learning in clinical pharmacology: a 5-year journey to a new course and increased students' self-confidence. [PDF]

BMC Med Educ
Rychlickova J, Siska F.
europepmc   +1 more source

Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd) in Patients with Hormone Receptor (HR) Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer. [PDF]

J Clin Pharmacol
Tang Z, Lim K, Jiang Y, Denduluri N, Rokutanda N, Pan Y, Hong Y, Ren S, Vajjah P, Zhou D.   +9 more
europepmc   +1 more source

Quantitative Systems Pharmacology Modeling Amid the Rise of Agentic AI. [PDF]

CPT Pharmacometrics Syst Pharmacol
Lu J, Desikan R.
europepmc   +1 more source

Correction to "Clinical Pharmacology Perspective on Direct-To-Subcutaneous Dosing of T Cell Engagers in Oncology First-In-Human Studies". [PDF]

Clin Transl Sci
europepmc   +1 more source